Enfusion (ENFN)

• Market cap: $1B
• 1 day: 1.53%
• 5 days: 0.28%
• 1 month: 7.48%
• 3 months: 18.37%
• 6 months: 30.27%
• Year to date: 13.45%
• 1 year: 10.16%
• 5 years: -46.34%
• 10 years: -46.34%
• Sector: Information Technology
• Industry: Prepackaged Software

About: Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Employees: 1,102

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

7,317% more call options, than puts

Call options by funds: $445K | Put options by funds: $6K

126% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 23

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

11% more capital invested

Capital invested by funds: $776M [Q2] → $861M (+$85.5M) [Q3]

8% more funds holding

Funds holding: 101 [Q2] → 109 (+8) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q2] → 4 (+0) [Q3]

1.67% less ownership

Funds ownership: 99.1% [Q2] → 97.42% (-1.67%) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $13 22% upside
• Avg. target: $13 22% upside
• High target: $13 22% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Stifel Parker Lane 66% 1-year accuracy 31 / 47 met price target

22% upside $13

Buy Maintained

18 Dec 2024